Filing Details
- Accession Number:
- 0001209191-20-049796
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-08 20:01:09
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-08 20:01:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1566044 | Vyne Therapeutics Inc. | VYNE | Pharmaceutical Preparations (2834) | 453757789 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1616284 | Andrew Saik | 520 U.s. Highway 22, Suite 204 Bridgewater NJ 08807 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-08 | 40,000 | $1.46 | 340,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares were purchased in multiple transactions at prices ranging from $1.4499 to $1.4767 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.